Phase 3
Completed N=69
Empowering Patients to Better Manage Diabetes Through Self-Care
Type I or Type II Diabetes (Excludes Gestational Diabetes)
Source: ClinicalTrials.gov NCT00254501 ↗
Enrolled (actual)
69
Serious AEs
0.0%
Results posted
Jul 2016
Primary outcomePrimary: Change in Hemoglobin A-1C From Baseline — -0.16; -0.50 percentage of glycolsylated hemoglobin — p=0.0757
◆ Published Evidence
Established
45citations · ~3 / year
A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study.
Summary
This study will look at the impact of health insurance benefits on self management of diabetes for people with this condition. Studies have shown that when people with diabetes manage their disease better, they stay healthier. Our goal in this study is to help those with diabetes better manage their disease (self-care). We will compare two types of health insurance benefits in this study. We want to see if one set of benefits improves self-care more than the other one.
Linked Publications
-
A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Hemoglobin A-1C From Baseline |
-0.16; -0.50 | 0.0757 |
| SECONDARY Changes From Baseline in LDL, HDL, Total Cholesterol, Triglycerides |
0.1; -3.9; -3.6; -6.3; -5.1; -11.6 | 0.44 |
| SECONDARY Changes in Economic Outcomes (Total Cost of Care, Cost of Diabetes Medications, Cost of Diabetes Supplies) From Baseline to 12 Months |
-89; 1612; 516; 450; 237; 191 | .3856 |
| SECONDARY Change in Diabetes Knowledge and Empowerment (Patient Self-efficacy) From Baseline to 12 Months |
0.29; 0.17; 0.25; -0.65; -0.14; 0.54 | 0.785 |
Eligibility Criteria
Inclusion Criteria
- diabetes (Type I or Type II)
- enrolled in health plan with participating employer
- age 18 or older
- willing and able to provide informed consent
Exclusion Criteria
- gestational diabetes
Data sourced from ClinicalTrials.gov (NCT00254501) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.